West Nile virus adheres to human red blood cells in whole blood

Clinical Infectious Diseases

Volumn 45, Issue 2, 2007, Pages 181-186

  Rios, Maria ^a,c   Daniel, Sylvester ^a   Chancey, Caren ^a   Hewlett, Indira K ^a   Stramer, Susan L ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b AMERICAN RED CROSS   (United States)

^c NIH Bldg 29 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ANIMAL CELL; ARTICLE; BLOOD TRANSFUSION REACTION; ERYTHROCYTE; HUMAN; HUMAN CELL; INFECTIOUS COMPLICATION; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK REDUCTION; VERO CELL; VIRUS ADSORPTION; VIRUS DETECTION; VIRUS INFECTIVITY; VIRUS LOAD; VIRUS TRANSMISSION; WEST NILE FLAVIVIRUS; BLOOD DONOR; BLOOD TRANSFUSION; ENDEMIC DISEASE; EPIDEMIOLOGY; FEMALE; ISOLATION AND PURIFICATION; MALE; MASS SCREENING; METHODOLOGY; NUCLEIC ACID AMPLIFICATION; PHYSIOLOGY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; UNITED STATES; VIRUS INFECTION;

BLOOD DONORS; BLOOD TRANSFUSION; ENDEMIC DISEASES; ERYTHROCYTES; FEMALE; HUMANS; MALE; MASS SCREENING; NUCLEIC ACID AMPLIFICATION TECHNIQUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA, VIRAL; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; UNITED STATES; VIRAL LOAD; WEST NILE FEVER; WEST NILE VIRUS;

EID: 34447092165     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/518850     Document Type: Article

References (26)

1. Davis LE, DeBiasi R, Goade DE, et al. West Nile virus neuroinvasive disease. Ann Neurol 2006; 60:286-300.
2. Centers for Disease Control and Prevention. ArboNet WNV report. Available at: http://www.cdc.gov/ncidod/dvbid/westnile/index.htm Accessed 23 February 2007.
3. Centers for Disease Control and Prevention. West Nile virus infection in organ donor and transplant recipients - Georgia and Florida, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:790.
4. Centers for Disease Control and Prevention. Investigations of West Nile virus infections in recipients of blood transfusions. MMWR Morb Mortal Wkly Rep 2002; 51:973-4.
5. Centers for Disease Control and Prevention. Update: investigations of West Nile virus infections in recipients of organ transplantation and blood transfusion - Michigan, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:879.
6. Centers for Disease Control and Prevention. Possible West Nile virus transmission to an infant through breast-feeding - Michigan, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:877-8.
7. Centers for Disease Control and Prevention. Update: West Nile virus screening of blood donations and transfusion-associated transmission-United States, 2003. MMWR Morb Mortal Wkly Rep 2004; 53: 281-4.
8. Busch MP, Tobler LH, Saldanha J, et al. Analytical and clinical sensitivity of West Nile virus RNA screening and supplemental assays available in 2003. Transfusion 2005; 45:492-9.
9. Centers for Disease Control and Prevention. Transfusion-associated transmission of West Nile virus - Arizona, 2004. MMWR Morb Mortal Wkly Rep 2004; 53:842-4.
10. Pealer LN, Marfin AA, Petersen LR, et al.; West Nile Virus Transmission Investigation Team. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003; 349: 1236-45.
11. Montgomery SP, Brown JA, Kuehnert M, et al.; 2003 West Nile Virus Transfusion-Associated Transmission Investigation Team. Transfusion-associated transmission of West Nile virus, United States 2003. Transfusion 2006; 46:2038-46.
12. Custer B, Tomasulo PA, Murphy EL, et al. Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: analysis of 2003 data to inform 2004 decision making. Transfusion 2004; 44:1547-54.
13. Stramer SL, Fang CT, Foster GA, Wagner AG, Brodsky JP, Dood RY. West Nile virus among blood donors in the United States, 2003 and 2004. N Engl J Med 2005; 353:451-9.
14. Busch MP, Caglioti S, Robertson EF, et al. Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing. N Engl J Med 2005; 353:460-7.
15. Youssefian T, Drouin A, Masse JM, Guichard J, Cramer EM. Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation. Blood 2002; 99:4021-9.
16. Lachgar A, Jaureguiberry G, Le Buenac H, et al. Binding of HIV-1 to RBCs involves the Duffy antigen receptors for chemokines (DARC). Biomed Pharmacother 1998; 52:436-9.
17. Lee TH, Stromberg RR, Henrard D, Busch MP. Effect of platelet-associated virus on assays of HIV-1 in plasma. Science 1993; 262: 1585-6.
18. Hess C, Klimkait T, Schlapbach L, et al. Association of a pool of HIV-1 with erythrocytes in vivo: a cohort study. Lancet 2002; 359:2230-4.
19. Rios M, Zhang MJ, Srinivasan K, et al. Monocytes/macrophages are a potential target in human infection with West Nile virus (WNV) through blood transfusion. Transfusion 2006; 46:659-67.
20. Rios M, Sirnivasan K, Wood O, et al. West Nile virus: correlation between infectivity and RNA copy number [abstract S9-030B]. Transfusion 2003; 43:3A.
21. Rios M, Bianco C. The role of blood group antigens in infectious diseases. Semin Hematol 2000; 37:177-85.
22. Garratty G. Blood groups and disease: a historical perspective. Transfus Med Rev 2000; 14:291-301.
23. Moulds JM, Moulds JJ. Blood group associations with parasites, bacteria, and viruses. Transfus Med Rev 2000; 14:302-11.
24. Tamasauskas D, Powell V, Saksela K, Yazdanbakhsh K. A homologous naturally occurring mutation in Duffy and CCR5 leading to reduced receptor expression. Blood 2001; 97:3651-4.
25. Branch DR, Sukac D, Ma X-Z, Mylvaganum M, Lingwood C. The Pk blood group antigen can act as a receptor for HIV-1 and Pk mimic can inhibit HIV-1 infection. Vox Sang 2002; 83(Suppl 2):136.
26. Macedo de Oliveira A, Beecham BD, Montgomery SP, et al. West Nile virus blood transfusion-related infection despite nucleic acid testing. Transfusion 2004; 44:1695-9.